Importance of Continuous Glucose Monitoring in Type 1 Diabetes Highlighted

by Madhumathi Palaniappan on  June 8, 2017 at 11:59 AM Diabetes News
RSS Email Print This Page Comment bookmark
Font : A-A+

Continuous glucose monitoring (CGM) in type 1 diabetes would support the value of CGM for reducing the variability in the blood glucose levels and the risk of both hypoglycemia and hyperglycemia. This could improve the patients' quality of life when compared to self-monitoring of blood glucose (SMBG).
Importance of Continuous Glucose Monitoring in Type 1 Diabetes Highlighted
Importance of Continuous Glucose Monitoring in Type 1 Diabetes Highlighted

The recent review of CGM trials and the impact of CGM accuracy for the future of automated insulin delivery systems that could focus two in a series of articles that are published in a special supplement to Diabetes Technology & Therapeutics (DTT).

Show Full Article


In the article entitled "Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes," David Rodbard, MD, Biomedical Informatics Consultants, Potomac, MD, concluded that CGM, as well as flash glucose monitoring, has been shown to be safe and effective, with the recent regulatory approval of certain CGM devices for nonadjunctive use to guide insulin dose adjustment representing a major advance.

In the "Future of Automated Insulin Delivery Systems," Jessica Castle, MD, Oregon Health & Science University, Portland, J. Hans DeVries, MD, University of Amsterdam, The Netherlands, and Boris Kovatchev, PhD, University of Virginia, Charlottesville, discuss how CGM has enabled the automation of insulin delivery.

The authors describe the rapid progress in the development of automated insulin delivery systems, the novel features and advantages they may offer for improving glycemic control, and the critical role that highly accurate CGM will play in the safe and effective use of these systems.

In the Editorial entitled "The Future of Continuous Glucose," DTT Editor-in-Chief Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver (Aurora) states: "Continuous glucose monitors have come a long way with significant improvement in accuracy and MARD of <10%." Just like all patients with new-onset T1D [type 1 diabetes] get an SMBG meter today, we hope in the very near future, all patients with new-onset T1D will receive CGM."

Research reported in this publication was supported by the National Institutes of Health under Award Number 1DP3DK101044-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

More News on:

Diabetic Retinopathy Diabetes Diabetic Diet Otitis Media Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Stress Relief Through Alternative Medicine Stress and the Gender Divide 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive